These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15777909)

  • 21. Cervical priming with misoprostol prior to transcervical procedures.
    Fiala C; Gemzell-Danielsson K; Tang OS; von Hertzen H
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S168-71. PubMed ID: 17961571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Misoprostol administered by epithelial routes: Drug absorption and uterine response.
    Meckstroth KR; Whitaker AK; Bertisch S; Goldberg AB; Darney PD
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):582-90. PubMed ID: 16946218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irreproducible results: good for surgeons, bad for scientists.
    Thillet J
    Fertil Steril; 2000 Jul; 74(1):189. PubMed ID: 10907921
    [No Abstract]   [Full Text] [Related]  

  • 24. [Misoprostol off label essential for women's health].
    Danielsson KG
    Lakartidningen; 2013 Nov 13-19; 110(46):2045-6. PubMed ID: 24380157
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of misoprostol before hysteroscopic surgery in non-pregnant premenopausal women: a randomized comparison of sublingual, oral and vaginal administrations.
    Lee YY; Kim TJ; Kang H; Choi CH; Lee JW; Kim BG; Bae DS
    Hum Reprod; 2010 Aug; 25(8):1942-8. PubMed ID: 20542898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical priming with sublingual misoprostol vs. 15-methyl-prostaglandin F2alpha prior to surgical abortion.
    Vimala N; Mittal S; Dadhwal V
    Int J Gynaecol Obstet; 2005 Feb; 88(2):134-7. PubMed ID: 15694088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect and risk analysis of misoprostol in stimulating cervical maturity for post-term pregnancy].
    Yin CY; Zhou JZ; Wang BP; Lü XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):182-4, 188. PubMed ID: 16503524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Making pregnancy safer in Myanmar: introducing misoprostol to prevent post-partum haemorrhage as part of active management of the third stage of labour.
    Htay TT
    Reprod Health Matters; 2007 Nov; 15(30):214-5. PubMed ID: 17938087
    [No Abstract]   [Full Text] [Related]  

  • 29. Irreproducible results: good for surgeons, bad for scientists.
    McDonough PG
    Fertil Steril; 2000 Jul; 74(1):189-90. PubMed ID: 10907922
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized controlled trial for cervical priming using vaginal misoprostol prior to hysteroscopy in women who have only undergone cesarean section.
    Kalampokas E; Sofoudis C; Antonogeorgos G; Panoulis K; Aravantinos L; Grigoriou O; Kalampokas T
    Arch Gynecol Obstet; 2012 Oct; 286(4):853-7. PubMed ID: 22592929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misoprostol: a quarter century of use, abuse, and creative misuse.
    Chong YS; Su LL; Arulkumaran S
    Obstet Gynecol Surv; 2004 Feb; 59(2):128-40. PubMed ID: 14752301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of misoprostol in gynaecology].
    Lesavre M; Legendre G; Fernandez H
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):190-4. PubMed ID: 24433990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misoprostol for cervical ripening before diagnostic hysteroscopy in nulliparous women.
    Bakas P; Hassiakos D; Liapis A; Creatsa M; Konidaris S; Gregoriou O
    Int J Gynaecol Obstet; 2012 Mar; 116(3):263-4. PubMed ID: 22169042
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized comparison of vaginal misoprostol and dinoprostone for cervical priming in nulliparous women before operative hysteroscopy.
    Preutthipan S; Herabutya Y
    Fertil Steril; 2006 Oct; 86(4):990-4. PubMed ID: 16949590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents.
    Sanchez-Ramos L; Kaunitz AM
    Obstet Gynecol; 1994 May; 83(5 Pt 1):799-801. PubMed ID: 8164948
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of sublingual use of 400 mcg prostaglandin E1 for first trimester surgical abortion according to parity: a retrospective study.
    Kalogiannidis I; Gitas G; Petousis S; Margioula-Siarkou C; Xenidis T; Dagklis T; Prapas N; Agorastos T
    Minerva Ginecol; 2013 Aug; 65(4):445-51. PubMed ID: 24051944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One or two day mifepristone-misoprostol interval for second trimester abortion.
    Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
    Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-cervical application of Misoprostol at estrus alters the content of cervical hyaluronan and the mRNA expression of follicle stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and cyclooxygenase-2 in the ewe.
    Leethongdee S; Kershaw-Young CM; Scaramuzzi RJ; Khalid M
    Theriogenology; 2010 Jun; 73(9):1257-66. PubMed ID: 20171717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mifepristone: new preparation. Avoids or facilitates cervical dilatation before vacuum aspiration of pregnancy.
    Prescrire Int; 2001 Oct; 10(55):135-40. PubMed ID: 11824427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of topical application of misoprostol on cervical relaxation in mares.
    McNaughten J; Pozor M; Macpherson M; Kelleman A; Woodward E; Troedsson M
    Reprod Domest Anim; 2014 Dec; 49(6):1057-62. PubMed ID: 25363694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.